Company / Operating Income
10x Genomics, Inc. Operating Income History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$61.0M
FY2025
5-year range
-$265.3M / -$52.3M
FY2021-FY2025
Trend
+68.7%
vs FY2024
Sector context
#117 of 151
Health Care
What the data says
10x Genomics, Inc.'s operating income of -$61M is lower than 77% of companies in the Health Care sector (FY2025). Operating Income has fluctuated over the past 9 years, ranging from -$534M in FY2020 to -$18M in FY2017.
Based on SEC 10-K filings.
-$61M in FY2025.
Improved from -$265M to -$61M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 23% in Health CareTop 77% of 151This company -$61.0M Sector average $716.7M
▼
-108.5% below sector average
Key checks
Key Insights
- In FY2025, operating income increased 68.7% year-over-year.
- Ranks #117 out of 151 companies in the Health Care sector.
- Peak operating income was recorded in FY2017.
- Lowest operating income in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -29.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$61.0M | +68.7% |
| FY2024 | -$194.6M | +26.7% |
| FY2023 | -$265.3M | -58.0% |
| FY2022 | -$167.9M | -221.4% |
| FY2021 | -$52.3M | +90.2% |
| FY2020 | -$534.1M | -1647.1% |
| FY2019 | -$30.6M | +72.4% |
| FY2018 | -$110.8M | -502.8% |
| FY2017 | -$18.4M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026